Skip to main content
PET shows promise in assessing tuberculosis meningitis treatments

Johns Hopkins University researchers who used PET found that the rate of rifampin penetration to tuberculosis meningitis lesions in rabbits dropped from 32% to 11% after two weeks of treatment, and a similar decline was observed among most human patients with TBM. The findings in Science Translational Medicine suggest that PET may be used to optimize TBM treatments and prompt the development of personalized treatments for methicillin-resistant Staphylococcus aureus and other serious infections, researchers said.

Full Story: